These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 37709934)

  • 1. Immunomodulation and immunopharmacology in heart failure.
    Markousis-Mavrogenis G; Baumhove L; Al-Mubarak AA; Aboumsallem JP; Bomer N; Voors AA; van der Meer P
    Nat Rev Cardiol; 2024 Feb; 21(2):119-149. PubMed ID: 37709934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications.
    Panahi M; Vadgama N; Kuganesan M; Ng FS; Sattler S
    J Clin Med; 2018 Oct; 7(11):. PubMed ID: 30384415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition.
    Panahi M; Papanikolaou A; Torabi A; Zhang JG; Khan H; Vazir A; Hasham MG; Cleland JGF; Rosenthal NA; Harding SE; Sattler S
    Cardiovasc Res; 2018 Sep; 114(11):1445-1461. PubMed ID: 30010800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory bioactive glasses for tissue regeneration.
    Zheng K; Niu W; Lei B; Boccaccini AR
    Acta Biomater; 2021 Oct; 133():168-186. PubMed ID: 34418539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives.
    Kessler EL; Oerlemans MIFJ; van den Hoogen P; Yap C; Sluijter JPG; de Jager SCA
    J Cardiovasc Transl Res; 2021 Feb; 14(1):63-74. PubMed ID: 32444946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunomodulatory mechanism of acupuncture treatment for ischemic stroke: research progress, prospects, and future direction.
    Kuang H; Zhu X; Chen H; Tang H; Zhao H
    Front Immunol; 2024; 15():1319863. PubMed ID: 38756772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients.
    Dulek DE; Fuhlbrigge RC; Tribble AC; Connelly JA; Loi MM; El Chebib H; Chandrakasan S; Otto WR; Diorio C; Keim G; Walkovich K; Jaggi P; Girotto JE; Yarbrough A; Behrens EM; Cron RQ; Bassiri H
    J Pediatric Infect Dis Soc; 2020 Dec; 9(6):716-737. PubMed ID: 32808988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach and Review of Contemporary Clinical Trials.
    Patel RB; Shah SJ
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():41-63. PubMed ID: 30296895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation for unexplained recurrent implantation failure: where are we now?
    Genest G; Banjar S; Almasri W; Beauchamp C; Benoit J; Buckett W; Dzineku F; Gold P; Dahan MH; Jamal W; Jacques Kadoch I; Kadour-Peero E; Lapensée L; Miron P; Shaulov T; Sylvestre C; Tulandi T; Mazer BD; Laskin CA; Mahutte N
    Reproduction; 2023 Feb; 165(2):R39-R60. PubMed ID: 36322478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of B Cells in Cardiomyopathy and Heart Failure.
    Bermea K; Bhalodia A; Huff A; Rousseau S; Adamo L
    Curr Cardiol Rep; 2022 Aug; 24(8):935-946. PubMed ID: 35689723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune system and chronic heart failure: is the heart in control?
    Fildes JE; Shaw SM; Yonan N; Williams SG
    J Am Coll Cardiol; 2009 Mar; 53(12):1013-20. PubMed ID: 19298913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cells drive new immunomodulatory therapies for myocardial infarction: From basic to clinical translation.
    Nian W; Huang Z; Fu C
    Front Immunol; 2023; 14():1097295. PubMed ID: 36761726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of immunomodulatory intervention in rheumatoid arthritis.
    Kavanaugh A
    Drugs Today (Barc); 1999; 35(4-5):275-86. PubMed ID: 12973432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.
    Gheorghiade M; Vaduganathan M; Ambrosy A; Böhm M; Campia U; Cleland JG; Fedele F; Fonarow GC; Maggioni AP; Mebazaa A; Mehra M; Metra M; Nodari S; Pang PS; Ponikowski P; Sabbah HN; Komajda M; Butler J
    Heart Fail Rev; 2013 Mar; 18(2):107-22. PubMed ID: 22581217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physical training as immunomodulatory treatment in chronic heart failure].
    Straburzyńska-Migaj E
    Przegl Lek; 2009; 66(7):384-7. PubMed ID: 20043581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoengineering the next generation of arthritis therapies.
    Klimak M; Nims RJ; Pferdehirt L; Collins KH; Harasymowicz NS; Oswald SJ; Setton LA; Guilak F
    Acta Biomater; 2021 Oct; 133():74-86. PubMed ID: 33823324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Energetics and Heart Failure: a Review of Recent Therapeutic Trials.
    Bhatt KN; Butler J
    Curr Heart Fail Rep; 2018 Jun; 15(3):191-197. PubMed ID: 29707741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint targeting antibodies hold promise for combinatorial cancer therapeutics.
    Ritu ; Chandra P; Das A
    Clin Exp Med; 2023 Dec; 23(8):4297-4322. PubMed ID: 37804358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis.
    Winter MP; Sulzgruber P; Koller L; Bartko P; Goliasch G; Niessner A
    Heart Fail Rev; 2018 Jul; 23(4):573-581. PubMed ID: 29862463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.